TPCW
INSP icon

TD Private Client Wealth’s Inspire Medical Systems INSP Stock Holding History

TD Private Client Wealth’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9
Closed -$464 – 1735
2026
Q1 		$464 Sell
9
-15
-63% -$1.05K ﹤0.01% 1498
2025
Q4 		$2.21K Buy
24
+6
+33% +$574 ﹤0.01% 1257
2025
Q3 		$1.34K Buy
18
+7
+64% +$709 ﹤0.01% 1293
2025
Q2 		$1.43K Buy
11
+6
+120% +$870 ﹤0.01% 1261
2025
Q1 		$796 Hold
5
– – ﹤0.01% 1310
2024
Q4 		$927 Buy
+5
New +$971 ﹤0.01% 1255
2024
Q2 		– Sell
-65
Closed -$14K – 1235
2024
Q1 		$14K Sell
65
-4
-6% -$784 ﹤0.01% 999
2023
Q4 		$14K Sell
69
-6
-8% -$972 ﹤0.01% 1006
2023
Q3 		$14.9K Buy
75
+23
+44% +$5.8K ﹤0.01% 975
2023
Q2 		$16.9K Hold
52
– – ﹤0.01% 971
2023
Q1 		$12.2K Buy
52
+23
+79% +$5.81K ﹤0.01% 1003
2022
Q4 		$7.3K Hold
29
– – ﹤0.01% 1045
2022
Q3 		$5.14K Buy
29
+1
+4% +$201 ﹤0.01% 1056
2022
Q2 		$5.12K Buy
+28
New +$5.58K ﹤0.01% 1060

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TD Private Client Wealth's INSP Position: Q2 2026 in Review

TD Private Client Wealth sold out of Inspire Medical Systems (INSP) in Q2 2026, closing a stake of 9 shares — an estimated $464 sold.

TD Private Client Wealth first reported a position in INSP in Q2 2022 and held it in 14 quarters. The position peaked at $16.9K in Q2 2023. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • TD Private Client Wealth reported no remaining Inspire Medical Systems position as of Q2 2026 after selling out during the quarter.
  • TD Private Client Wealth sold 9 Inspire Medical Systems shares in Q2 2026, an estimated $464.
  • TD Private Client Wealth first reported a position in Inspire Medical Systems in Q2 2022 and held it in 14 quarters.
  • TD Private Client Wealth's Inspire Medical Systems position peaked at $16.9K in Q2 2023.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.